A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 5, 2013, Pages 475-478

  Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

antibody; Ebola virus; epitope; filovirus; glycoprotein; immunization; neutralization; secreted glycoprotein; vaccine

Indexed keywords

GLYCOPROTEIN; NEUTRALIZING ANTIBODY; SECRETED GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENIC SUBVERSION; ARTICLE; CROSS REACTION; DNA IMMUNIZATION; EBOLA VIRUS; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; VIRUS NEUTRALIZATION;

EID: 84877030654     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.13.30     Document Type: Article

References (20)

1. Sanchez A, Geisbert TW, Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott, Williams & Wilkins, PA, USA, 1410-1448 (2007
2. Volchkov VE, Becker S, Volchkova VA et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214(2), 421-430 (1995
3. Mehedi M, Falzarano D, Seebach J et al. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85(11), 5406-5414 (2011
4. Mohan GS, Li W, Ye L, Compans RW, Yang C. Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog. 8(12), e1003065 (2012
5. Ito H, Watanabe S, Takada A, Kawaoka Y. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75(3), 1576-1580 (2001
6. Volchkova VA, Feldmann H, Klenk HD, Volchkov VE. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 250(2), 408-414 (1998).
7. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454(7201), 177-182 (2008
8. Yang Z, Delgado R, Xu L et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279(5353), 1034-1037 (1998
9. Kindzelskii AL, Yang Z, Nabel GJ, Todd RF 3rd, Petty HR. Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-To-CR3 proximity on neutrophils. J. Immunol. 164(2), 953-958 (2000
10. Sui J, Marasco WA. Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor. Virology 303(1), 9-14 (2002
11. Maruyama T, Buchmeier MJ, Parren PWHI, Burton DR. Ebola virus, neutrophils and antibody specificity. Science 282, 843a (1998
12. Wahl-Jensen VM, Afanasieva TA, Seebach J, Ströher U, Feldmann H, Schnittler HJ. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J. Virol. 79(16), 10442-10450 (2005
13. Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genovamic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J. Infect. Dis. 204(Suppl. 3), S941-S946 (2011
14. Baize S, Leroy EM, Georges-Courbot MC et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5(4), 423-426 (1999
15. Volchkov VE, Volchkova VA, Muhlberger E et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291(5510), 1965-1969 (2001
16. Towner JS, Amman BR, Sealy TK et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5(7), e1000536 (2009).
17. Ramanan P, Edwards MR, Shabman RS et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc. Natl Acad. Sci. USA 109(50), 20661-20666 (2012
18. Valmas C, Grosch MN, Schümann M et al. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog. 6(1), e1000721 (2010
19. Friedrich BM, Trefry JC, Biggins JE et al. Potential vaccines and post-exposure treatments for filovirus infections. Viruses 4(9), 1619-1650 (2012
20. Wilson JA, Hevey M, Bakken R et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287(5458), 1664-1666 (2000